Sequential tamoxifen and megestrol acetate with continuous norethisterone in postmenopausal breast cancer: A feasibility study

Breast

Volumn 5, Issue 2, 1996, Pages 92-95

  Bissett, D ^a   Harnett, A N ^a   Canney, P A ^a   McMurray, A ^a   Leake, R ^c   George, W D ^b   Paul, J ^a   Kaye, S B ^a  

^a BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEGESTROL ACETATE; NORETHISTERONE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HOT FLUSH; HUMAN; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; SWEATING; THROMBOPHLEBITIS; VAGINA BLEEDING;

EID: 0030005817     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(96)90128-9     Document Type: Article

References (11)

1. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet 1992; 339: 1-15, 71-85.
2. Gil P G, Gebski V, Snyder R et al. Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer. Ann Oncol 1993; 4: 741-744.
3. Horwitz K B, Koseki Y, McGuire W L. Oestrogen control of progesterone receptor in human breast cancer: role of oestradiol and antioestrogen. Endocrinology 1978; 103: 1750-1752.
4. Noguchi S, Miyauchi K, Nishizawa Y, Koyama H. Induction of progesterone receptor with tamoxifen in human breast cancer with special reference to its behaviour over time. Cancer 1988; 61, 1345-1349.
5. Waseda N, Kato Y, Imura H, Kurata M. Effects of tamoxifen on oestrogen and progesterone receptors in human breast cancer. Cancer Res 1981; 41: 1984-1988.
6. Crawford D J, George W D, Smith D C et al. Comparison of cyclical tamoxifen and megestrol acetate with tamoxifen alone in advanced breast cancer. Breast 1992; 1: 35-40.
7. Christiansen C, Riis B J. Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern. Br J Obstet Gynaecol 1990; 97: 1087-1092.
8. Whitehead J, Brunier H. PEST 2.0. The PEST project, Department of Applied Statistics, University of Reading 1989.
9. Whitehead J. The use of the sequential probability ratio test for monitoring the percentage germination of accessions to seed banks. Biometrics 1991; 37: 129-136.
10. Fisher B, Costantino J P, Redmond C K et al. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994; 86: 527-37.
11. Kedar R P, Bourne T H, Powles T J et al. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 1994; 343: 1318-1821.